Back

Hypertensive heart disease vs. Transthyretin cardiac amyloidosis: what are the differential features in real life?

1 July 2021 (14:00 - 15:00)
Organised by:
Congress Presentation Part of: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure and Hypertension Hypertension, Other HFA Premium Access Heart Failure 2021

About the speaker

Photo
Doctor Cristina Goena Vives

Donostia University Hospital, Donostia (Spain)

6 More presentations in this session

Presentation thumbnail
Serum proteome profiling reflects the risk of pulmonary hypertension in chronic heart failure patients
Mr J. Morze (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Association of right ventricular deformation parameters and pulmonary hypertension markers in patients with asymptomatic primary mitral regurgitation and preserved left ventricular ejection fraction
Ms R. Dirsiene (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence for prediction of pulmonary arterial hypertension detection using computer tomography
Doctor T. Kivrak (Elazig, TR)
Abstract Slides Video
Presentation thumbnail
Real-life evidence of the use of subcutaneous treprostinil in pulmonary hypertension in Argentina
Doctor J. Soricetti (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Association between right ventricle size and function on outcomes in COVID-19
Doctor N. Bodagh (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure and Hypertension

The Event

Event poster

Heart Failure 2021

1 July 2021 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources